![Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider](https://adkhabar.com/depoquc/accelerated-mobile-pages/images/SD-default-image.png)
![Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider](https://i2.wp.com/ml-eu.globenewswire.com/media/YzE0NTAzYzMtNzcwMS00NWRjLWJhMTAtM2I1ZjkxM2JkZjI0LTEyMjA5NDYtMjAyNS0wNC0wNC1lbg==/tiny/Zelluna-ASA.png?w=1920&resize=1920,19&ssl=1)
Oslo, Norway, 4 April, 2025 - Reference is made to the stock exchange notice published by Zelluna ASA (the "Company")…
![Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement](https://i1.wp.com/ml-eu.globenewswire.com/media/MjU1NjVjOWEtMTBjOC00MTE0LWI0NTUtYjdlMjkzODM0MzYzLTEyMjA5NDY=/tiny/Zelluna-ASA.png?w=1&resize=1,1&ssl=1)
March 03, 2025 10:46 ET | Source: Zelluna ASA Oslo, Norway, 03 March, 2025 - Zelluna ASA, a company pioneering…
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its fourth…
Accessibility: Skip TopNav December 18, 2024 02:00 ET | Source: Ultimovacs ASA Issuer name: Ultimovacs ASA Ex. date: 18 December…
